Design and synthesis of novel benzofurans as a new class of antifungal agents targeting fungal N-myristoyltransferase.: Part 2

被引：79

作者：

Ebiike, H

Masubuchi, M

Liu, PL

Kawasaki, K

Morikami, K

Sogabe, S

Hayase, M

Fujii, T

Sakata, K

Shindoh, H

Shiratori, Y

Aoki, Y

Ohtsuka, T

Shimma, N

机构：

[1] Nippon Roche Res Ctr, Dept Chem, Kanagawa 2478530, Japan

[2] Nippon Roche Res Ctr, Dept Mycol, Kanagawa 2478530, Japan

[3] Nippon Roche Res Ctr, Dept Preclin Sci, Kamakura, Kanagawa 2478530, Japan

来源：

BIOORGANIC & MEDICINAL CHEMISTRY LETTERS | 2002年 / 12卷 / 04期

关键词：

D O I：

10.1016/S0960-894X(01)00808-3

中图分类号：

R914 [药物化学];

学科分类号：

100701 ;

摘要：

Modification of the C-2 position of a benzofuran derivative 6 (RO-09-4609), an N-myristoyltransferase (Nmt) inhibitor, has led us to discover antifungal agents that are active in a murine systemic candidiasis model. The drug design is based on the analysis of a crystal structure of a Candida Nmt complex with 2. The optimization has been guided by various biological evaluations including a quasi in vivo assay and pharmacokinetic analysis. (C) 2002 Elsevier Science Ltd. All rights reserved.

引用

页码：607 / 610

页数：4

共 9 条

[1] Metabolism-based drug interactions involving oral azole antifungals in humans
Benedetti, MS
Bani, M
[J]. DRUG METABOLISM REVIEWS, 1999, 31 (03) : 665 - 717
[2] Cassette dosing: rapid in vivo assessment of pharmacokinetics
Frick, LW
Adkison, KK
Wells-Knecht, KJ
Woollard, P
Higton, DM
[J]. PHARMACEUTICAL SCIENCE & TECHNOLOGY TODAY, 1998, 1 (01): : 12 - 18
[3] THE NATURE OF PI-PI INTERACTIONS
HUNTER, CA
SANDERS, JKM
[J]. JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, 1990, 112 (14) : 5525 - 5534
[4] TARGETED GENE REPLACEMENT DEMONSTRATES THAT MYRISTOYL-COA/PROTEIN N-MYRISTOYLTRANSFERASE IS ESSENTIAL FOR VIABILITY OF CRYPTOCOCCUS-NEOFORMANS
LODGE, JK
JACKSONMACHELSKI, E
TOFFALETTI, DL
PERFECT, JR
GORDON, JI
[J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1994, 91 (25) : 12008 - 12012
[5] Synthesis and antifungal activities of novel 1,3-β-D-glucan synthase inhibitors.: Part 1
Masubuchi, K
Okada, T
Kohchi, M
Sakaitani, M
Mizuguchi, E
Shirai, H
Aoki, M
Watanabe, T
Kondoh, O
Yamazaki, T
Satoh, Y
Kobayashi, K
Inoue, T
Horii, I
Shimma, N
[J]. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2001, 11 (03) : 395 - 398
[6] Design and synthesis of novel benzofurans as a new class of antifungal agents targeting fungal N-myristoyltransferase.: Part 1
Masubuchi, M
Kawasaki, K
Ebiike, H
Ikeda, Y
Tsujii, S
Sogabe, S
Fujii, T
Sakata, K
Shiratori, Y
Aoki, Y
Ohtsuka, T
Shimma, N
[J]. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2001, 11 (14) : 1833 - 1837
[7] INVITRO ACTIVITY OF SCH39304 IN COMPARISON WITH AMPHOTERICIN-B AND FLUCONAZOLE
MEUNIER, F
LAMBERT, C
VANDERAUWERA, P
[J]. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1990, 25 (02) : 227 - 236
[8] 1,1'-(AZODICARBONYL)DIPIPERIDINE-TRIBUTYLPHOSPHINE, A NEW REAGENT SYSTEM FOR MITSUNOBU REACTION
TSUNODA, T
YAMAMIYA, Y
ITO, S
[J]. TETRAHEDRON LETTERS, 1993, 34 (10) : 1639 - 1642
[9] GENETIC-STUDIES REVEAL THAT MYRISTOYLCOA-PROTEIN N-MYRISTOYLTRANSFERASE IS AN ESSENTIAL ENZYME IN CANDIDA-ALBICANS
WEINBURG, RA
MCWHERTER, CA
FREEMAN, KS
WOOD, DC
GORDON, JI
LEE, SC
[J]. MOLECULAR MICROBIOLOGY, 1995, 16 (02) : 241 - 250

← 1 →